IL118364A0 - A hepatitis C virus-derived composition methods for the preparation thereof and assays for the detection of hepatitis C virus - Google Patents

A hepatitis C virus-derived composition methods for the preparation thereof and assays for the detection of hepatitis C virus

Info

Publication number
IL118364A0
IL118364A0 IL11836496A IL11836496A IL118364A0 IL 118364 A0 IL118364 A0 IL 118364A0 IL 11836496 A IL11836496 A IL 11836496A IL 11836496 A IL11836496 A IL 11836496A IL 118364 A0 IL118364 A0 IL 118364A0
Authority
IL
Israel
Prior art keywords
hepatitis
virus
assays
preparation
detection
Prior art date
Application number
IL11836496A
Other languages
English (en)
Original Assignee
Bionova Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionova Corp filed Critical Bionova Corp
Publication of IL118364A0 publication Critical patent/IL118364A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL11836496A 1995-05-22 1996-05-22 A hepatitis C virus-derived composition methods for the preparation thereof and assays for the detection of hepatitis C virus IL118364A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44727695A 1995-05-22 1995-05-22

Publications (1)

Publication Number Publication Date
IL118364A0 true IL118364A0 (en) 1996-09-12

Family

ID=23775707

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11836496A IL118364A0 (en) 1995-05-22 1996-05-22 A hepatitis C virus-derived composition methods for the preparation thereof and assays for the detection of hepatitis C virus

Country Status (3)

Country Link
AU (1) AU5924396A (xx)
IL (1) IL118364A0 (xx)
WO (1) WO1996037606A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078500B1 (en) 1998-01-30 2006-07-18 The General Hospital Corporation Genetic immunization with nonstructural proteins of hepatitis C virus
WO1999038880A1 (en) * 1998-01-30 1999-08-05 The General Hospital Corporation Genetic immunization with nonstructural proteins of hepatitis c virus
GB0226722D0 (en) * 2002-11-15 2002-12-24 Glaxo Group Ltd Vaccine
BR102018071672A2 (pt) * 2018-10-22 2021-11-16 Fundação Oswaldo Cruz Polipeptídeo, cassete de expressão, vetor de expressão, célula hospedeira, kit para triagem imunológica de hcv e/ou diagnóstico de hepatite c, composição, uso de pelo menos um polipeptídeo, e, métodos para produzir um polipeptídeo, para triagem imunológica de hcv e para o diagnóstico de hepatite c

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
UA41266C2 (uk) * 1990-04-04 2001-09-17 Чірон Корпорейшн Комбінація послідовностей епітопів вірусу гепатиту с (hcv), спосіб виявлення антитіл до вірусу гепатиту с (hcv), набір для виконання аналізу при виявленні антитіл до антигену гепатиту с (hcv)
NZ238681A (en) * 1990-06-25 1992-03-26 Univ Osaka Res Found Non-a, non-b hepatitis virus particles and their production
GB9203803D0 (en) * 1992-02-21 1992-04-08 Wellcome Found A recombinant polypeptide
KR100312535B1 (ko) * 1993-04-30 2002-06-20 성재갑 혼합항원을이용한씨(c)형간염바이러스의항체진단방법

Also Published As

Publication number Publication date
WO1996037606A1 (en) 1996-11-28
AU5924396A (en) 1996-12-11

Similar Documents

Publication Publication Date Title
AU1447492A (en) Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
PL324906A1 (en) Vaccines against viral hepatitis of c type
PL321966A1 (en) Vaccine against viral hepatitis of b type
AU3241095A (en) Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
PL335721A1 (en) Novel methods of screening serving the purpose of identifying the factors of selective hepatitis c virus replication inhibition
AU1566595A (en) Method and reagent for inhibiting hepatitis c virus replication
AU2064297A (en) Hepatitis c virus ribozymes
IL118471A0 (en) A positive-stranded RNA virus-derived composition methods for making compositions utilizing the same assays for the detection of and vaccines against said viruses
AU1905399A (en) Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
AU3238995A (en) Hepatitis a virus receptor and methods of use
AU7224591A (en) A rapid and sensitive test for detecting hepatitis a virus
AU2683792A (en) Peptide based hepatitis c virus immunoassays
EP0711310A4 (en) HUMANE ANTIBODIES AGAINST VARICELLA-ZOSTER VIRUS
AU5679394A (en) Hepatitis b virus vaccines
AU3073389A (en) Production of monoclonal antibodies specific for non-a, non-b hepatitis infected liver
AU2370592A (en) Epitopes of the env protein of the hepatitis c virus
IL118364A0 (en) A hepatitis C virus-derived composition methods for the preparation thereof and assays for the detection of hepatitis C virus
AU4554899A (en) Novel hepatitis c virus peptides and uses thereof
HU9303066D0 (en) Particle forming multiply hepatitis b virus surface proteins
ZA964094B (en) Compositions and methods for the diagnosis of and vaccination against hepatitis c virus (hcv)
ZA964446B (en) Oligonucleotides specific for hepatitis c virus
AU3966995A (en) Peptides for detection of hepatitis c antibodies
AU688259B2 (en) Hepatitis C virus peptides
AU1439195A (en) Monoclonal antibodies to hepatitis e virus and methods for using same
GR970300022T1 (en) Peptide capable of being recognised by antibodies recognising the C33 antigen of hepatitis C virus